BioRestorative Therapies, Inc. Common Stock (NV) (BRTX) is a publicly traded Healthcare sector company. As of September 7, 2026, BRTX trades at $0.15 with a market cap of $4.09M and a P/E ratio of -0.14. BRTX moved +1.25% today. Year to date, BRTX is -87.40%; over the trailing twelve months it is -90.75%. Its 52-week range spans $0.14 to $2.55. Rallies surfaces BRTX's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies community data for BRTX shows anonymized retail investor ownership, positioning, sentiment, and portfolio context when enough community data is available.
| Metric | Value |
|---|---|
| Price | $0.15 |
| Market Cap | $4.09M |
| P/E Ratio | -0.14 |
| EPS | $-1.07 |
| Dividend Yield | 0.00% |
| 52-Week High | $2.55 |
| 52-Week Low | $0.14 |
| Volume | 0 |
| Avg Volume | 0 |
| Revenue (TTM) | $357.87K |
| Net Income | $-11.06M |
| Gross Margin | 92.09% |
BRTX analyst coverage data. Average price target: $0.00.